Acute angle closure glaucoma in a patient admitted at the intensive care unit for the management of COVID-19.
RE Ruiz Lozano, CA Galvan-Lopez… - … American Journal of …, 2021 - search.ebscohost.com
Drug-induced acute angle closure glaucoma (AACG) is a blinding condition that requires
urgent management. Unfavorable conditions encountered at the intensive care unit (ICU) …
urgent management. Unfavorable conditions encountered at the intensive care unit (ICU) …
[PDF][PDF] Incidence of acute angle-closure glaucoma in Dalmatia, southern Croatia
L Bojiæ, Z Mandiæ, M Ivaniševiæ, K Buèan… - …, 2004 - academia.edu
Aim. To investigate the incidence of acute angle-closure glaucoma among residents of
Dalmatia, southern part of Croatia. Methods. We reviewed hospital records of 176 patients …
Dalmatia, southern part of Croatia. Methods. We reviewed hospital records of 176 patients …
[HTML][HTML] The seasonality of acute attack of primary angle-closure glaucoma in Beijing, China
In this study, the seasonality of acute attack of primary angle-closure glaucoma (PACG) was
analysed. This retrospective case series included 283 patients (200 women, 83 men; mean …
analysed. This retrospective case series included 283 patients (200 women, 83 men; mean …
Use of glaucoma medications: state of the science and directions for observational research
VH Lu, I Goldberg, CY Lu - American journal of ophthalmology, 2010 - Elsevier
PURPOSE: To summarize observational studies that focus on the use of glaucoma
medications and to identify gaps in knowledge to guide future investigation. DESIGN …
medications and to identify gaps in knowledge to guide future investigation. DESIGN …
Relationship between open-angle glaucoma and stroke: a 2010 to 2012 Korea National Health and Nutrition Examination Survey
Purpose: To determine the relationship between open-angle glaucoma (OAG) and stroke in
the Korean population. Materials and Methods: This study was a population-based, cross …
the Korean population. Materials and Methods: This study was a population-based, cross …
[HTML][HTML] Resource utilization among glaucoma patients in the UK treated with beta-blocker and Non-Beta-Blocker adjunctive therapy: a retrospective cohort analysis
A Viswanathan, C Spera, A Mullins, D Covert… - Advances in …, 2017 - Springer
Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …
Chronic angle-closure glaucoma related to paroxetine treatment
MA Sierra-Rodriguez, F Saenz-Frances… - Seminars in …, 2013 - Taylor & Francis
Purpose: To present a unique case of a 33-year-old woman using paroxetine who presented
with acute unilateral visual loss due to chronic angle-closure glaucoma. Methods: Case …
with acute unilateral visual loss due to chronic angle-closure glaucoma. Methods: Case …
Assessing open angle glaucoma as an independent risk factor for stroke
H Sadek, IS Shaikh, ST Elsamna… - … & Visual Science, 2021 - iovs.arvojournals.org
Purpose: Glaucoma is a leading cause of vision-threatening disease worldwide and its open-
angle variant has previously been explored as a risk factor for stroke. Using a large sample …
angle variant has previously been explored as a risk factor for stroke. Using a large sample …
Comparison of medical comorbidity between patients with primary angle-closure glaucoma and a control cohort: a population-based study from Taiwan
HY Chen, CL Lin - BMJ open, 2019 - bmjopen.bmj.com
Objective To determine the prevalence and risk of systemic comorbidities in primary angle-
closure glaucoma in Taiwan population. Methods We included 3322 primary angle-closure …
closure glaucoma in Taiwan population. Methods We included 3322 primary angle-closure …
Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open‐Angle Glaucoma
We sought to refine understanding about associations identified in prior studies between
angiotensin‐II receptor blockers, metformin, selective serotonin reuptake inhibitors, fibric …
angiotensin‐II receptor blockers, metformin, selective serotonin reuptake inhibitors, fibric …